These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19532077)

  • 1. Drug-drug interactions involving new antiretroviral drugs and drug classes.
    Soodalter J; Sousa M; Boffito M
    Curr Opin Infect Dis; 2009 Feb; 22(1):18-27. PubMed ID: 19532077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and drug-drug interactions of antiretrovirals: an update.
    Dickinson L; Khoo S; Back D
    Antiviral Res; 2010 Jan; 85(1):176-89. PubMed ID: 19665485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance: a clinical approach.
    Yazdanpanah Y
    Curr Opin HIV AIDS; 2009 Nov; 4(6):499-506. PubMed ID: 20048717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigational agents for salvage.
    Pozniak AL
    Curr Opin HIV AIDS; 2009 Nov; 4(6):524-30. PubMed ID: 20048721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug interactions between proton pump inhibitors and antiretroviral drugs.
    McCabe SM; Smith PF; Ma Q; Morse GD
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):197-207. PubMed ID: 17428151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-drug interactions with newer antiretroviral agents.
    Aberg JA
    Top HIV Med; 2008 Dec; 16(5):146-50. PubMed ID: 19106429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of dosage adjustments used to manage antiretroviral drug interactions.
    Park-Wyllie LY; Levine MA; Holbrook A; Thabane L; Antoniou T; Yoong D; Kam D; Bayoumi AM
    Clin Infect Dis; 2007 Oct; 45(7):933-6. PubMed ID: 17806064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents.
    McCance-Katz EF
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S89-95. PubMed ID: 16265622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antiretrovirals and new combinations.
    Havlir DV; Lange JM
    AIDS; 1998; 12 Suppl A():S165-74. PubMed ID: 9632999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drug targets for HIV.
    Bean P
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S96-100. PubMed ID: 16265623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging antiretroviral drug interactions.
    Pham PA; Flexner C
    J Antimicrob Chemother; 2011 Feb; 66(2):235-9. PubMed ID: 21131695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable.
    Seden K; Back D; Khoo S
    J Antimicrob Chemother; 2009 Jul; 64(1):5-8. PubMed ID: 19398457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of genotypic resistance to the newer antiretroviral drugs in HIV-1-infected patients with virological failure.
    Llibre JM; Schapiro JM; Clotet B
    Clin Infect Dis; 2010 Mar; 50(6):872-81. PubMed ID: 20158400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral drug treatment of CNS HIV-1 infection.
    Yilmaz A; Price RW; Gisslén M
    J Antimicrob Chemother; 2012 Feb; 67(2):299-311. PubMed ID: 22160207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to novel drug classes.
    Marcelin AG; Ceccherini-Silberstein F; Perno CF; Calvez V
    Curr Opin HIV AIDS; 2009 Nov; 4(6):531-7. PubMed ID: 20048722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin-antiretroviral interactions.
    Liedtke MD; Rathbun RC
    Ann Pharmacother; 2009 Feb; 43(2):322-8. PubMed ID: 19196837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status and challenges of antiretroviral research and therapy.
    Esté JA; Cihlar T
    Antiviral Res; 2010 Jan; 85(1):25-33. PubMed ID: 20018390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What does the generalist need to know about HIV infection?
    Gallant JE
    Adv Chronic Kidney Dis; 2010 Jan; 17(1):5-18. PubMed ID: 20005484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.